Health Systems and Populations, Faculty of Medicine and Health Sciences
Behzad Hajari is a clinical epidemiologist and a fellow of Australian National Health and Medical Research Council (NHMRC). He trained as a Medical Practitioner and has a Masters in Public Health (MPH) and PhD in Medicine. He is also a Lecturer in the University of New South Wales.
MD, MPH, PhD
- Natural history of acute and chronic HCV infection
- HCV management and barriers to care in prison and among people who inject drugs
- HBV management among culturally and linguistically diverse people
- Grebely J, Lamoury F, Hajarizadeh B, et al. Evaluation of the Xpert® HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: A prospective study. The Lancet Gastroenterology & Hepatology 2017 [Epub ahead of print]. DOI: doi.org/10.1016/S2468-1253(17)30075-4
- The Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. The Lancet Gastroenterology and Hepatology 2017;2(3):161-76.
- Hajarizadeh B, Grebely J, McManus H, et al. Chronic hepatitis C burden and care cascade in Australia in the era of interferon-based treatment. Journal of Gastroenterology and Hepatology 2017;32(1):229-36
- Hajarizadeh B, Grebely J, Martinello M, Matthews GV, Lloyd AR, Dore GJ. The Lancet Gastroenterology and Hepatology 2016;1(4):317–327
- Hajarizadeh B, Grebely J, Dore GJ. Epidemiology and natural history of HCV infection. Nature Reviews Gastroenterology & Hepatology. 2013;10(9):553-62.
Recent Grant Success
- The impact of improving hepatitis C treatment on hepatocellular carcinoma (Cancer Council New South Wales: $440,000)
- Risk of hepatitis C reinfection among people with current injecting drug use following successful HCV treatment (National Health and medical research Council: $2,250,000)
- Early Career Fellowship (National Health and medical research Council: $315,000)